Institutional shares held 0
0 calls
0 puts
Total value of holdings $0
$0 calls
$0 puts
Market Cap N/A
Institutional ownership N/A
# of Institutions 1

Quarterly Institutional Activity in APRE

Shares Bought
Shares Sold
View Transactions

Latest Institutional Activity in APRE

Top Purchases

Q4 2024
Concourse Financial Group Securities, Inc. Shares Held: 0 ($0)
Q1 2024
Nbc Securities, Inc. Shares Held: 899 ($1.62K)
Q1 2023
Princeton Global Asset Management LLC Shares Held: 100 ($180)
Q1 2023
Quent Capital, LLC Shares Held: 3 ($5.4)
Q4 2022
Jane Street Group, LLC Shares Held: 51K ($91.7K)

Top Sells

Q1 2023
State Street Corp Shares Held: 0 ($0)
Q4 2022
Renaissance Technologies LLC Shares Held: 179K ($323K)
Q4 2022
Morgan Stanley Shares Held: 276K ($497K)
Q4 2022
Advisor Group Holdings, Inc. Shares Held: 5.05K ($9.09K)
Q4 2022
Susquehanna International Group, LLP Shares Held: 13.4K ($24.1K)

About APRE

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATRN-DDRi. Aprea Therapeutics, Inc. is based in Boston, Massachusetts.


Insider Transactions at APRE

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
64.5K Shares
From 12 Insiders
Grant, award, or other acquisition 16.4K shares
Open market or private purchase 48.1K shares
Sell / Disposition
6.46K Shares
From 1 Insiders
Open market or private sale 6.46K shares

Track Institutional and Insider Activities on APRE

Follow Aprea Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APRE shares.

Notify only if
Any

Insider Trading

Get notified when an Aprea Therapeutics, Inc. insider buys or sells APRE shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Aprea Therapeutics, Inc.

Track Activities on APRE